or Try an Advanced Search...

    Technical Analysis for VIGL - Vigil Neuroscience, Inc.

    Grade Last Price % Change Price Change
    B 4.37 9.25% 0.37
    VIGL closed up 9.25 percent on Monday, July 1, 2024, on 1.3 times normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical VIGL trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish 0.00%
    Crossed Above 200 DMA Bullish 0.00%
    180 Bullish Setup Bullish Swing Setup 0.00%
    Wide Bands Range Expansion 0.00%
    Fell Below 200 DMA Bearish 9.25%
    Volume Surge Other 9.25%
    Inside Day Range Contraction 9.25%
    Wide Bands Range Expansion 9.25%
    Crossed Above 20 DMA Bullish -2.46%
    Crossed Above 200 DMA Bullish -2.46%
    Older End-of-Day Signals for VIGL ...

       Recent Intraday Alerts

    Alert Time
    20 DMA Support about 8 hours ago
    Rose Above 200 DMA about 8 hours ago
    Rose Above 10 DMA about 8 hours ago
    1.5x Volume Pace about 8 hours ago
    Down 3% about 8 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    VIGL Chart by TradingView
    Basic chart:

    Profile

    Vigil Neuroscience, Inc., a biotechnology company, discovers and develops novel therapeutics that take advantage of breakthroughs in science and human genetics of microglia. It harnesses the power of microglia for the treatment of neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. The company was incorporated in 2020 and is based in Cambridge, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Neurodegenerative Diseases Treatment Of Neurodegenerative Diseases Human Physiology

    Is VIGL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 27 Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E
    Jun 27 Biggest stock movers today: BB, MU, and more
    Jun 27 Vigil Neuroscience Announces $40 Million Strategic Investment from Sanofi
    Jun 26 Augustine Therapeutics raises €17M in series A first closing
    Jun 5 These 2 ‘Strong Buy’ Penny Stocks Are Poised for a Massive Rally, Say Analysts
    Apr 17 Vigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual Meeting
    Mar 24 Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans?
    Mar 20 Vigil Neuroscience appoints Kaufmann as Chief Medical Officer
    Mar 20 Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer
    Mar 12 Vigil Neuroscience to Present at Stifel 2024 Virtual CNS Days
    See more VIGL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 10.2201
    52 Week Low 2.47
    Average Volume 594,733
    200-Day Moving Average 4.04
    50-Day Moving Average 3.50
    20-Day Moving Average 4.02
    10-Day Moving Average 4.04
    Average True Range 0.54
    RSI (14) 56.52
    ADX 27.78
    +DI 27.46
    -DI 16.52
    Chandelier Exit (Long, 3 ATRs) 4.44
    Chandelier Exit (Short, 3 ATRs) 4.09
    Upper Bollinger Bands 5.12
    Lower Bollinger Band 2.93
    Percent B (%b) 0.66
    BandWidth 54.35
    MACD Line 0.17
    MACD Signal Line 0.19
    MACD Histogram -0.0159
    Fundamentals Value
    Market Cap 156.78 Million
    Num Shares 35.9 Million
    EPS -2.02
    Price-to-Earnings (P/E) Ratio -2.16
    Price-to-Sales 0.00
    Price-to-Book 0.75
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.28
    Resistance 3 (R3) 5.20 4.81 5.13
    Resistance 2 (R2) 4.81 4.57 4.85 5.08
    Resistance 1 (R1) 4.59 4.43 4.70 4.67 5.03
    Pivot Point 4.20 4.20 4.25 4.24 4.20
    Support 1 (S1) 3.98 3.97 4.09 4.07 3.71
    Support 2 (S2) 3.59 3.82 3.63 3.66
    Support 3 (S3) 3.37 3.59 3.61
    Support 4 (S4) 3.46